Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Fluorodeoxyglucose F18
  • Neoplastic Cells, Circulating
  • Positron-Emission Tomography
  • Tomography, X-Ray Computed

abstract

  • Detection of five or more CTCs during therapeutic monitoring can accurately predict prognosis in MBC beyond metabolic response. FDG-PET/CT deserves a role in patients who have fewer than five CTCs at midtherapy. Prospective trials should evaluate the most sensitive and cost-effective modality for therapeutic monitoring in MBC.

publication date

  • July 10, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2008.19.4423

PubMed ID

  • 19451443

Additional Document Info

start page

  • 3303

end page

  • 11

volume

  • 27

number

  • 20